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ABSTRACT 
Infertility is a disease of the reproductive system defined by the failure to achieve a clinical 
pregnancy after 12 months or more of regular unprotected sexual intercourse. As one of the 
leading causes of anovulatory infertility, it is believed that 5-10% of the reproductive-aged female 
population is living with polycystic ovary syndrome. Ayurveda considers the excellence of 4 
factors- Ritu (ovulatory phase), Kshetra (Garbhasaya), Ambu (proper nourishment to embryo), 
and Bija (healthy sperm and ovum) for a successful pregnancy. Impairment to any of these factors 
leads to Vandhytva or pregnancy failure. This case study helps to plan a treatment protocol for the 
patient with PCOS having infertility. A 25 yr old female having regular cycles came to OPD of 
Streeroga of IPGT & RA, having the complaints of weight gain and failure to conceive since 2 year 
of active married life. On presentation she was a medium sized woman with android body habits 
and had mild hirsute and acanthosis nigricans over nape of neck. Gynaecological examination 
revealed a normal sized uterus with no other abnormalities. Sonography revealed bulky ovaries 
with multiple small follicles with no evidence of ovulation along with small fibroids on anterior 
wall (1.8cm×1.5cm) and posterior wall (2.7cm×2.8cm). Her husband’s semen analysis was 
normal. Based on clinical findings and investigation, anovulatory factor infertility due to PCOS 
was diagnosed along with fibroid. Virechana and Samana were decided due to both of these 
factors and Sthanyasodhana gana kashaya was selected as Samana drug. Treatment was done for 
3 months, during treatment itself ovulation occurred and the patient conceived after 3 months. 
This case being a Krichrasadhya vyadhi, proper care was taken including correction of the lifestyle 
and food habits. This case will help to understand the importance of Sodhana in gynecological 
disorders and explore the probable mode of action of Sthanyasodhana gana kashaya which helped 
in menstrual regulation. 
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INTRODUCTION
 Infertility has been a major medical and social 
preoccupation since the dawn of human existence 
and women have always been the symbol of fertility. 
In fact both men and women are equally responsible 
for infertility, although 10% of all cases will remain 
unexplained. Infertility is a disease of the 
reproductive system defined by the failure to achieve 
a clinical pregnancy after 12 months or more of 
regular unprotected sexual intercourse. [1] The WHO 
estimates the overall prevalence of primary infertility 
in India to be between 3.9 and 16.8 %. [2] The main 
causes of female infertility are: the age of the patient, 
the high incidence of polycystic ovarian syndrome, 
which is related to anovulation and the presence of 
endometriosis. Other important causes such as pelvic 
infection, myomas especially sub mucous and 
cervical factors should be ruled out..  As many as 20% 
of women with infertility problems (including 
fecundability and early pregnancy loss) have been 
diagnosed with PCOS.[3] The polycystic ovary 
syndrome (PCOS) is a syndrome of ovarian 
dysfunction along with the cardinal features of 
Hyperandrogenism and polycystic ovarian 
morphology.[4] The patient complains of increasing 
obesity (abdominal-50%), menstrual abnormalities 
(70%) in the form of Oligomenorrhoea, Amenorrhea 
or Dysfunctional uterine bleeding (DUB) and 
Infertility.[5] Though symptomatic treatments are 
available for controlling hyperinsulinaemia, ovulation 
induction, oral hormonal therapy & surgical 
intervention for correcting the PCOS but no definitive 
treatment is of success. In addition, it may produce 
some iatrogenic systemic disorders. Fibroids prevent 
rhythmic uterine contractions during intercourse and 
hinder the sperm transport and hence adversely 
affect fertility. Fibroids also cause congestion and 
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dilatation of the endometrial venous plexus, which 
causes defective implantation and leads to early 
abortion. 
In Ayurvedic classics, majority of 
Gynaecological disorders have been described under 
the 8 Artava dushti and 20 Yonivyapads. PCOS cannot 
be included in any one of the Yonivypad due to its 
various symptomatology and complex interactions 
with various systems. Ayurveda explained mainly 
four etiological factors like unhealthy lifestyle 
(Mithyachara), menstrual disorders (Artava dushti), 
genetic defects (Beeja Dosha) and certain unknown 
factors (Daivata) are responsible for the 
development of female genital disorders[6] and it 
seems that all these aetiologies contribute to the 
development of PCOS as a whole. Mithyachara along 
with existing Artava dushti plays an important role in 
the pathogenesis of PCOS as well as fibroids. As the 
ultimate effect of Artava dushti being Abeejatva 
(anovulation), diagnosis and treatment of Artava 
dushti is of most important as it hinders the main 
function of female genital tract. Uterine fibroids are 
mostly considered as Garbhasaya arbuda having Vata 
kapha predominance and Asraya in Mamsa. 
According to Susruta, the excellence of 4 factors ie, 
Ritu (ovulatory phase), Kshetra (Garbhasaya), Ambu 
(proper nourishment to embryo), and Bija (healthy 
sperm and ovum) are essential for conception and a 
successful pregnancy.[7] In this case, anovulation 
denotes the absence of Ritukala and fibroids leads to 
distortion in Kshetra (Garbhasaya). Fibroids may also 
cause impairment in the blood supply and 
nourishment to embryo during the pregnancy, leads 
to early pregnancy loss. 
Despite the growing incidence of this 
syndrome, limited research has been done that 
encompasses the entirety of PCOS Spectrum. The 
indefinite diagnostic criteria in addition to its 
immense complexity make PCOS a challenging area of 
research. PCOS can be considered as a Vatakapha 
predominant Tridoshoja vyadhi mainly affecting the 
reproductive system. Infertility due to multiple 
etiologies is always serious concern to patients as 
well as to physicians. There are different treatment 
modalities in Ayurveda which gives promising results 
in the management of infertility due to PCOS. This 
case is a humble attempt to introduce a different way 
of drug selection which was based on the basic 
principles of Ayurveda.  
Case Report 
Presenting Complaints: A 25 yr old female who was 
a house wife came to OPD of Streeroga department of 
IPGT& RA, Jamnagar on 10 August 2016, having the 
complaints of weight gain and failure to conceive 
since 2 years of active married life. 
History of present illness: She narrated her history 
of presenting complaints as follows, after 3 years of 
menarche at the age of 16 yrs she had developed the 
complaint of irregular and increased menstrual 
bleeding during her periods and done all 
investigations and found to be normal. She took 
Ayurvedic treatment and complaints got relieved. 
After 7 years, she got married with a non-
consanginous man of age 29 yrs. In 2016 March at the 
age of 25 yrs, she went to a gynecologist for the 
complaint of failure to conceive even after 2 years of 
active married life. During that time her cycles were 
regular and had no history of abortion, MTP or 
contraceptives. During the evaluation of infertility, 
sonography revealed a posterior wall subserosal 
fibroid (2.2×1.8) cm, and both ovaries were bulky 
with multiple small follicles. She took medicine for 2-
3 month and discontinued after that. Then the patient 
came to OPD of IPGT & RA.  
Family History: Father was hypertensive 
Personal History: On analyzing her habits, it was 
found that the patient had the history of intake of 
high carbohydrate diet along with sedentary lifestyle. 
She had a normal appetite and bladder habit and 
occasional constipation with irregular sleep habits. 
Husband Factor: Husband - Private Job. Semen 
analysis was normal.  
General Examination: On presentation she was a 
medium sized woman, with android body habits. Her 
height was 154 cm, weight 65 kg, Body mass index of 
27.4kg/m2 and blood pressure of 120/80 mm of Hg. 
The patient was mild hirsute (over lips, chin and 
abdomen) and acanthosis nigricans over nape of the 
neck.  
Gynecological examination: An anteverted normal 
sized uterus with no other abnormalities. 
Investigations: The blood values of the patient 
before treatment (B.T.) and after treatment (A.T.) are 
as under i.e. Table No 1.  
Table No 1: Laboratory investigations 
Hematology B.T. A.T. Differential WBC Count (%) B.T. A.T. 
Total WBC (/ Cu.mm) 7200 9200 Neutrophils 55 56 
Hb (g %) 11.07 11 Lymphocytes 39 37 
E.S.R.(mm / First hr / 14 40 Eosinophils 3 4 
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Westergren.) 
   Monocytes 3 3 
Biochemistry B.T. A.T. Biochemistry B.T. A.T. 
FBS (mg/dL) 81 56 S.Insulin( m IU/L) 9 11.2 
PPBS(mg/dl) 90 70 S. TSH(μU/ml) 1.839 1.839 
S.Cholesterol (mg/dL) 136 122 S. Testosterone (ng/dL) 24.35 22.7 
S. Triglyceride(mg/dl) 122 57 S.Prolactin(ng/ml) 7.6 8.1 
   Glycosylated Hb 5.6 5.1 
USG Findings 
July 2016: Sonography showed multiple uterine fibroid, one on posterior wall (2.7×2.8cm) and other on 
anterior wall (1.8×1.5cm). Follicular study by ultrasonography showed no ovulation with multiple small 
follicles. Sonography report of patient during treatment is as depicted in Table 2. 
Table 2: Ovulation study 
Date Day of LMP Right ovary Left ovary Endometrium  
10/8/16 5th day 10cc 11.2cc 
8×10 mm follicle  
4.2mm PCOD++ 
20/8/16 15th day  - 20×20 mm 
follicle - 
 4.8mm  
22/8/16 17th day -  CLH  4.8mm ovulation++ 
11/9/16 4th day   -  -  3 mm  
7/11/16 5th day 8.1cc 9cc 5mm  
12/11/16 10th day  16×14mm  -  4.4mm  
14/11/16 12th day 18×16mm  -  4.4mm  
17/11/16 15th day Ruptured follicle  -  Ovulation++ 
 Based on the clinical findings and investigations, the anovulatory factor infertility due to polycystic 
ovarian syndrome was diagnosed. Here uterine fibroids were also a risk for conception and pregnancy. The 
treatment was mainly aimed to restore the fertility potential of the patient by regulating the menstrual cycle 
and ovulatory cycle, and preventing the further growth of fibroids.  
The treatment protocol included both Sodhana and Samana. The procedure of Sodhana chikitsa is depicted in 
Table No.3  
1. Sodhana Chikitsa  
Table No.3: Sodhana Chikitsa 
No. Procedure Drug & Dose Duration 
1 Deepana, Pachana Trikatu Churna 3 gm BD with luke warm water 3 Days (from 5th 
day of menses) 
2 Snehapana ShudhaGoghrita (Started with 20 ml and 
gradually increased upto 120 ml on 7th day) 
7 Days 
3 Sarvanga Abhyanga & 
Sweda 
BalaTaila – 2 times a day 2 Days 
4 Abhyanga, Swedana, 
Virechana  Karma 
Trivritaleha – 100 gm (empty stomach) 1 Day 
5 Sansarjana Karma Dietary regimen  7 Days 
* Dose of Sneha decided as per the appetite of patient and time taken for the digestion of Sneha. 
*The patient showed Samyak snigdha lakshanas like loose stools, aversion to ghee, tiredness and an oily skin on 
7th day 
 *After the intake of Trivrut lehyam, 10- 12 Vegas were noted with no other complications. 
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2. Samana Chikitsa: Sthanyasodhana gana kashaya 
(11) 48ml BD, ½ hr before food was given for next 3 
months. The patient was advised to do proper 
exercise (walking ½ hr regularly in the morning) and 
maintain low calorie healthy diet. 
Follow up and Outcomes: After the Virechana the 
weight of patient was reduced to 62kg. During the 
treatment, sonography was done to evaluate the 
follicular status and ovulation and on 22nd August 
2016 ovulation study became positive. The patient 
was advised regular coitus with husband during the 
ovulation period. In November sonography is done to 
evaluate the ovarian size and it is found that volume 
also reduced significantly. Again the patient came on 
9th January 2017 with the complaint of missed 
periods. Her last menstrual period was on 2/12/16. 
The patient was advised to do urine pregnancy test 
and was found to be positive. The pregnancy went on 
with mild complications like back ache, constipation 
etc and an elective caesarian section was planned due 
to complicated pregnancy. On 1st September she 
delivered a female baby having weight 3.1kg through 
elective caesarian section. 
DISCUSSION 
 There is no direct correlation of polycystic 
ovarian syndrome in Ayurveda. On review of 
Ayurvedic literature, there are many conditions 
which may be point towards the symptomatology 
and complications of PCOS. By analyzing the causes of 
Yonivyapad, Mithyachara and Artavadushti having a 
crucial role in the pathogenesis of PCOS. Early 
diagnosis and treatment of Artava dushti is of most 
important as it further leads to Abeejatva 
(Anovulation) [12] and thus infertility. In this case, 
multiple fibroids were also diagnosed having direct 
impact on reproductive capability. All the metabolic 
manifestations of the disease may be due to the 
Dhatvagni mandya existed at the level of Rasa, Rakta, 
Mamsa, and Medo dhatu. Sodhana and Samana is an 
essential part of Ayurvedic management of PCOS. 
Since it is a metabolic disorder, Virechana was 
planned for normalising the functions of Pitha and 
Agni. Trivrut leha was selected for Virechana due to 
its Tridoshahara (especially Kaphahara) and Hridya 
properties. Thus Sodhana helped to eliminate the 
vitiated Doshas and removed the Srotodushti existed 
at the level of Rasa, Rakta, Mamsa, Medas and 
Artavavahasrotas. To maintain Agni and proper 
formation of Artava, Sthanyasodhana gana kashaya 
was selected. Stanya and Artava being the Upadhatus 
of Rasadhatu[13], Sthanyasodhana kashaya may have 
an action in the proper formation and excretion of 
Artava also. Artava having the synonym Pushpa 
denotes Stribeeja (ovum) also. Stanyasodhana gana 
also known as Pathadi gana contains Patha, Sunti, 
Devadaru, Musta, Murva, Guduchi, Vatsaka Phala, 
Kiratat ikta, Katurohini and Sariba.  Most of the drugs 
having Tikta Katu rasa, Laghu, Rooksha guna, Ushna 
veerya and Katu vipaka and Deepana, Pachana, 
Kaphahara in action. All these properties helped in 
removing the Sanga, correction of the Agni, and 
normal functioning of Vata especially Apana and thus 
helped in proper formation and excretion of Artava 
(regularization of menstrual cycle and ovulatory 
cycle) and maintained its normal function, that is 
Garbhakrit.[14] Here the drug action was augmented 
due to Sodhana. Finally the cycles became ovulatory 
and the patient ultimately conceived. In most of the 
cases multiple uterine subserosal fibroids didn’t 
affect the conception and maintenance of pregnancy 
and in this case the size of fibroids didn’t show an 
increasing tendency during pregnancy also, which 
was a favoring factor for the pregnancy. 
Table 4: Ingredients of Trikatu churna 
No Drug name Latin Name Part 
1 Sunti Zingiber officinale Roscoe 1 
2 Marich Piper nigrum Linn. 1 
3 Pippali Piper longum Linn. 1 
Table 5: Ingredients of Trivrita leha 
No Drug name Latin Name Part 
1 Trivrita (Kwath) Operculina turpenthum Linn. 2 
2 Sugar Saccharum officinarum Linn. 2 
3 Trivrita Churna) Operculina turpenthum Linn 1 
4 Honey Mal depuratum 1 
5 Twak Cinnamomum zeylanicum Breyn. 1/24 
6 Tamalapatra Cinnamomum tamala Nees and Eberm. 1/24 
7 Marich Piper nigrum Linn. 1/24 
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Table 6: Ingredients in Stanyasodhana kashaya and their properties 
Drug Botanical name Pharmacological properties Part used 
Patha Cissampelos pareira L. Hypoglycemic, antioxidant, and 
anti-inflammatory [15] 
Whole 
plant 
Sunti Zingiber officinale Roscoe Immunomodulatory, anti-inflammatory, 
antidiabetic and antioxidant [16] 
Rhizome 
Devadaru Cedrus deodara Roxb. Antihyperlipidemic,[17] antiinflammatory,[18] 
immunomodulatory,[19] antioxidant[20] 
Bark 
Musta Cyperus rotundus Linn.  anti-inflammatory,[21] antioxidant[22] Rhizome 
Murva Marsdenia tenacissima Roxb. Antiinflammatory[23]  Stem 
Guduchi Tinospora cordifolia Miers.  Immunomodulatory,[24] antioxidant[25] Stem 
Kiratatikta Swertia chirata Buch-Ham Hypoglycemic, anti-inflammatory and 
antioxidant [26] 
Whole 
Plant 
Kutajaphala Holarrhena antidysenterica 
Wall 
Antioxidant and antidiabetic,  
anti hyperlipidemic, Hypotensive[27] 
Seed 
Katurohini Picrorrhiza kurroa Royle ex 
Benth. 
Antioxidant and anti neoplastic,[28] 
antidiabetic,[29] hepatoprotective [30] 
Rhizome 
Sariba Hemidesmus indicus R.Br. Antioxidant and free radical scavenging,[31,32] Root 
 There is emerging evidence now that chronic 
low inflammation is often present in women with 
PCOS with the possible role of increased Oxidative 
stress. Oxidative stress (OS) occurred as results of 
imbalance between pro-oxidants and antioxidants. 
Further elevated Reactive Oxygen Species(ROS) are 
being considered responsible for insulin resistance 
and Hyperandrogenism.[33] Gonzalez et al in their 
study observed that there is generation of ROS from 
mononuclear cells which occurred in response to 
hyperglycemia in women with PCOS.[34] Reports show 
that women with PCOS, both with obesity and normal 
weight, exhibit elevated serum TNF, C-reactive 
protein (CRP), monocyte and lymphocyte circulating 
levels, and inflammatory infiltration in ovarian 
tissue[35]. On analysing the stanyasodhana gana most 
of the drugs are having antioxidant, anti-
inflammatory, antihyperlipidemic and hypoglycaemic 
properties. The drug may help to reduce the 
oxidative stress by its antioxidant properties, thus 
helps in maintaining a proper balance between pro 
oxidants and antioxidants.  
CONCLUSION 
 Infertility seems to be increasing now days 
due to the change in lifestyle and stressful life of 
partners. PCOS which causing 80% anovulation, is 
one of the main contributing factor for female 
infertility. Although PCOS is one of the most common 
endocrine disorders in women of reproductive age, 
there is currently no cure for polycystic ovary 
syndrome. For this reason, early diagnosis of the 
disease based on established criteria is important. 
Obesity, insulin resistance as well as the associated 
diseases can be controlled by an early diagnosis and 
proper management. Though this study involves a 
single case, it may helpful for practitioners to find 
new way of thinking of treatment options and tried to 
explore the probable mode of action of drug based on 
recent researches on PCOS. Along with medicines 
proper exercise and a healthy diet was advised, this is 
very much essential for lifestyle diseases like PCOS. 
Sodhana comes in the main stream of Ayurvedic 
management of chronic diseases as it helps to 
eliminate the disease at the root level.  
Acknowledgment 
 We are thankful to our patient for the 
indispensable reconstruction of her case history and, 
most of all, for her willingness to use her anonymized 
data for this publication.  
REFERENCES 
1. WHO-ICMART revised glossary 
2. World Health Organization. Infecundity, 
infertility, and childlessness in developing 
countries. DHS Comparative Reports No 9. 
Calverton, Maryland, USA: ORC Macro and the 
World Health Organization; 2004 
3. Diamanti-Kandarakis E, Kouli C, Tsianateli T, 
Bergiele A. Therapeutic effects of metformin on 
insulin resistance and hyperandrogenism in 
polycystic ovary syndrome. Eur J Endocrinol. 
1998; 138:269–274. [PubMed: 9539300} 
4. Indian obstetrics and Gynecology-Journal for 
Basic and clinical research. Vol.1.No:2, Apr-Jun 
2011. 
Int. J. Ayur. Pharma Research, 2018;6(1):19-25 
     Available online at: http://ijapr.in  24 
5. Hiralal Konar. DC Dutta’s Textbook of 
Gynecology. 7th edition, New Delhi. Jaypee 
Brothers Medical Publishers (P) Ltd.2016, pp 
378-382 
6. Charaka Samhita, Text with Chakrapanidatta 
teeka, Jai Krishnadas Ayurveda Series 165. 
Chaukhamha Orientalia,Varanasi,Ch.Chi.30/8 
7. Sushrutha Samhita, text with Dalhana teeka, 
Krishna das Ayurveda Series 51. Chaukhamba 
Krishna Das Academy, Varanasi. Su.Sha.2/33 
8. Astanga Hridaya Samhita, text with Ayurveda 
Rasayana and Sarvanga Sundara teeka, Jaya 
Krishna Das Ayurveda Series 52, Chaukhsmba 
Orientalia, Varanasi.A.H.Su.6/164. 
9. Astanga Hridaya Samhita, text with Ayurveda 
Rasayana and Sarvanga Sundara teeka, Jaya 
Krishna Das Ayurveda Series 52, Chaukhsmba 
Orientalia, Varanasi.A.H.Chi.21/73-81. 
10. Astanga Hridaya Samhita, text with Ayurveda 
Rasayana and Sarvanga Sundara teeka, Jaya 
Krishna Das Ayurveda Series 52, Chaukhsmba 
Orientalia Varanasi.A.H. Kalpa Sidhi.2/9. 
11. Charaka Samhita, Text with Chakrapanidatta 
teeka, Jai Krishnadas Ayurveda Series 
165.Chaukhamha Orientalia,Varanasi,Ch.Su.4/18 
12. Sushrutha Samhita, text with Dalhana teeka, 
Krishna das Ayurveda Series 51. Chaukhamba 
Krishna Das Academy, Varanasi. Su.Sha.2/5 
13. Charaka Samhita, Text with Chakrapanidatta 
teeka, Jai Krishnadas Ayurveda Series 165. 
Chaukhamha Orientalia,Varanasi, Ch.Chi.15/17. 
14. Sushrutha Samhita, text with Dalhana teeka, 
Krishna das Ayurveda Series 51.Chaukhamba 
Krishna Das Academy, Varanasi. Su.Su.15/5. 
15. Arora Manu, Sharma Tanvi, Devi Anu, Bainsal 
Neeraj, Siddiqui Anees Ahmad, An inside review 
of Cissampelos pareira Linn.: A potential 
medicinal plant of India. International Research 
Journal of Pharmacy 2012: 3(12): 38-40 
16. Rajesh Kumar Mishra, Anil Kumar, Asok Kumar. 
Pharmacological activity of Zingiber officinale. 
International Journal of Pharmaceutical and 
Chemical Sciences.2012, Vol 1 (3),1422-1425 
17. Patil S, Prakash T, Kotresha D, Rao N R,Pandy N, 
Antihyperlipidemic potential of Cedrus deodara 
extracts in monosodiumglutamate induced 
obesity in neonatal rats. Indian J Pharmacol. 2011 
Nov; 43(6) 
18. Rathor.R.S and Goyal.H.R.1973, Studies on anti-
inflammatory and anti arthritic activity of an 
Indian Medicinal Plant, Cedrus deodara. Indian J 
Pharmacol 5,334-343 
19. Gupta P.P, Kulshreshta. D.K, and Patnaik G.K 
1997, Antiallegic activity of Cedrus deodara,  J 
Med Aromat Plant Sci19,1007-1008. 
20. Tiwari A.K, Srinivas. P.V, Kumar S.P. and Rao J 
M.2001. Free radical scavenging active 
components from Cedrus deodara. J Agric Food 
Chem 49, 4642-4645. 
21. Gupta M.B, Palit T.K, Singh.N and Bhargava 
K.P.1971. Pharmacological studies to isolate the 
active constituents from Cyperus rotundus 
possessing anti-inflammatory, antipyretic, and 
analgesic activities. Indian J Med Res 59,76-82 
22. Soumaya KJ, Dhekra M, Fadwa C, Zied G, Ilef L, 
Kamel G, Leila CG. Pharmacological, antioxidant, 
genotoxic studies and modulation oF rat 
splenocyte functions by Cyperus routundus 
extracts. BMC Complement Altern Med. 2013 Feb 
6;13:28. 
23. Bharath kumar,  Rohini A, Laxmi Suma Palivela, 
Samatha Y. Anti-nociceptive, anti inflammatory 
and antiarthritic activity of marsdenia 
tenacissima stem extract, International Journal of 
Phytopharmacology. 5(6), 2014, 411-415. 
24. Sharma U, Bala M, Kumar N, Singh B, Munshi RK, 
Bhalero S. Immunomodulatory active compounds 
from Tinospora cordifolia. J Ethnopharmacol. 
2012 Jun 14;141(3) 918-26. 
25. Sivakumar V, Rajan MS. Anti-oxidant Effect of 
Tinospora cordifolia Extract in Alloxan induced 
Diabetic Rats. Indian J Pharm Sci.2010 Nov;72(6): 
795-8. 
26. Vijaykumar, Johannes Van Staden, A Review of 
Swertia chirayita (Gentianaceae) as a Traditional 
Medicinal Plant. Front Pharmacol.2015; 6:308 
27. Snehadri Sinha, Aiswarya Sharma, P Hemalatha 
Reddy, Brijesh Rathi, N V S R K Prasad, Amit 
Vashishtha. Evaluation of phytochemical and 
pharmacological aspects of Holarrhena 
antidysenterica (Wall.): A Comprehensive review 
Journal of Pharmacy Research.6(2013) 488-492 
28. Rajkumar V, Guha G, Kumar RA. Antioxidant and 
anti-neoplastic activities of Picrorhiza kurroa 
extracts. Food Chem Toxicol. 2011 Feb; 49(2): 
363-9. 
29. Husain GM, Singh PN, Kumar V, Antidiabetic 
activity of standardized extract of Picrorhiza 
kurroa in rat model of NIDDM. Drug Discov 
Ther.2009 Jun; 3(3):88-92. 
30. Rahman S, Sultana S. Protective effects of 
Picrorhiza kurroa extract against 2-
acetylaminoflourene- induced hepatotoxicity in 
Wistar rats. J.Environ Pathol Toxicol Oncol. 2007; 
26(3):195-205. 
Archana.S et al. Primary Infertility Due to Polycystic Ovarian Syndrome Associated with Multiple Uterine Fibroids 
     IJAPR | January 2018 | Vol 6 | Issue 1  25 
31. Saravanan N, Nalini N. Antioxidant effect of 
Hemidesmus indicus on ethanol induced 
hepatotoxicity in rats. J. med Food. 2007 Dec; 
10(4):675-82. 
32. Ramakrishna V, Gopi S, Setty OH, Protective effect 
of Hemidesmus indicus L.R Br. against 
bromobenzene induced mitochondrial 
dysfunction in rat kidney. Am J Chin Med. 2012; 
40(3): 560-80. 
33. Sajal Gupta, Neena Malhotra, Dipika Sharma, 
Anjali Chandra, Agarwal Ashok, Oxidative Stress 
and its Role in Female Infertility and Assisted 
Reproduction: Clinical Implications, Royan 
Institue International Journal of Fertility and 
Sterility Vol 2, No 4, Feb-Mar 2009, Page: 15 
34. Gonzalez F, Rote NS, Minium J, Kirwan JP. 
Reactive oxygen species-induced oxidative stress 
in the development of insulin resistance and 
hyperandrogenism in polycystic ovary syndrome. 
J Clin Endocrinol Metab. 2006; 91: 336-340.  
35. Y. L. Xiong, X. Y. Liang, X. Yang, Y. Li, and L. N. Wei. 
Low-grade chronic inflammation in the 
peripheral blood and ovaries of women with 
polycystic ovarian syndrome, European Journal 
of Obstetrics Gynecology and Reproductive 
Biology, vol. 159, no. 1, pp. 148–150, 2011  
 
 
 
 
 
 
 
Disclaimer: IJAPR is solely owned by Mahadev Publications - A non-profit publications, dedicated to publish quality research, while 
every effort has been taken to verify the accuracy of the content published in our Journal. IJAPR cannot accept any responsibility or 
liability for the articles content which are published. The views expressed in articles by our contributing authors are not necessarily 
those of IJAPR editor or editorial board members.  
Cite this article as:  
Archana.S, Kalepandit, Anu.M.S, L P Dei. Ayurvedic Management of 
Primary Infertility Due to Polycystic Ovarian Syndrome Associated with 
Multiple Uterine Fibroids: A Case Report. International Journal of 
Ayurveda and Pharma Research. 2018;6(1):19-25. 
Source of support: Nil, Conflict of interest: None Declared 
 
*Address for correspondence 
Dr Archana.S  
PhD Scholar,  
Department of Prasuti-Streeroga, 
IPGT&RA, Jamnagar 
Email: archanas875@gmail.com 
